CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...